Taro Receives FDA Approvals for Ciclopirox Topical Solution, 8% (Nail Lacquer) and Grape Flavor Formulation of ... (Business Wire via Yahoo! Finance)
HAWTHORNE, N.Y.----Taro Pharmaceutical Industries Ltd. reported today that it has received approvals from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Ciclopirox Topical Solution, 8% and its Supplemental ANDA for Loratadine Syrup , 5 mg/5 mL in a grape flavored formulation, an over-the-counter product.

Taro Pharma Industries Gets FDA Approval For Its "ANDA" Of Ciclopirox Topical Solution - Quick Facts (Nasdaq)
(RTTNews) - Taro Pharmaceutical Industries Ltd. (TAROF.PK) announced that it has received approvals from the U.S. Food and Drug Administration for its Abbreviated New Drug Application or "ANDA" for Ciclopirox Topical Solution, 8% (Nail Lacquer) ("ciclopirox nail lacquer") and its Supplemental ANDA for Loratadine Syrup (Oral Suspension), 5 mg/5 mL ("loratadine syrup") in a grape flavored ...

Review combination drugs on lines of US FDA: medical expert (PharmaBiz)
Even as some half hearted efforts are on in the country to weed out irrational combination drugs from the market, experts in the medical field have called for a comprehensive review of all the combination drugs available in the country on the lines of the US FDA action way back in 1970.